Optimal metabolite curve fitting for kinetic modeling of 11C-WAY-100635

Journal of Nuclear Medicine

Volumn 48, Issue 6, 2007, Pages 926-931

  Wu, Songmei ^a   Ogden, R Todd ^b,c,d   Mann, J John ^c,d   Parsey, Ramin V ^c,d  

^a NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^b School of Public Health ^*  (United States)

^c New York Presbyterian Columbia University Medical Center   (United States)

^d NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Kinetic modeling; Nonlinear modeling; Residual analysis

Indexed keywords

CARBON 11; DRUG METABOLITE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE C 11; SEROTONIN 1A RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG METABOLISM; HUMAN; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

BRAIN; CARBON RADIOISOTOPES; HUMANS; MODELS, BIOLOGICAL; NONLINEAR DYNAMICS; PIPERAZINES; POSITRON-EMISSION TOMOGRAPHY; PYRIDINES; RADIOPHARMACEUTICALS; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN ANTAGONISTS;

EID: 34250363918     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.106.038075     Document Type: Article

References (18)

1. Fisher PM, Meltzer CC, Ziolko SK, Price JC, Hariri AR. Capacity for 5-HT(1A)-mediated autoregulation predicts amygdala reactivity. Nat Neomsci. 2006;9: 1362-1363.
2. Parsey RV, Olvet DM, Oquendo MA, Huang YY, Ogden RT, Mann JJ. Higher 5-HT1A receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study. Neuropsychopharmacology. 2006;31:1745-1749.
3. Parsey RV, Oquendo MA, Ogden RT, et al. Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY 100635 positron emission tomography study. Biol Psychiatry. 2006;59:106-113.
4. Borg J, Andree B, Lundberg J, Halldin C, Farde L. Search for correlations between serotonin 5-HT1A receptor expression and cognitive functions: a strategy in translational psychopharmacology. Psychopharmacology (Berl). 2006;185: 389-394.
5. Bailer UF, Frank GK, Henry SE, et al. Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [carbonyl11C]WAY-100635. Arch Gen Psychiatry. 2005;62: 1032-1041.
6. 11C]WAY- 100635 in humans: comparison of arterial and reference tissue input functions. J Cereb Blood Flow Metab. 2000;20:1111-1133.
7. 11C]NNC 756. Synapse. 1999;32:93-109.
8. 11C]choline: implications for in vivo imaging with positron emission tomography. Eur J Nucl Med. 2000;27:25-32.
9. 123I]ADAM and SPECT. J Nucl Med. 2001;42:1556-1562.
10. 3H]WAY-100635 as an in vivo radioligand for 5-HT1A receptors in rat brain. Eur J Pharmacol. 1994;271:515-523.
11. Carson RE, Wu Y, Lang L, et al. Brain uptake of the acid metabolites of F-18-labeled WAY 100635 analogs. J Cereb Blood Flow Metab. 2003;23:249-260.
12. 11C]WAY-100635 for PET. Neuroimage. 1998;8:426-440.
13. Oikonen V, Allonen T, Nagren K, Kajander J, Hietala J. Quantification of [carbonyl-(11)C]WAY-100635 binding: considerations on the cerebellum. Nucl Med Biol. 2000;27:483-486.
14. Akaike H. Information theory and an extension of the maximum likelihood principle. In: Petrov BN, Csaki F, eds. Proceedings of the 2nd International Symposium on Information Theory. Budapest. Hungary: Akademiai Kiado: 1973;267-281.
15. Hill AV. The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves. J Physiol (Lond). 1910;40:4-7.
16. Huang SC, Barrio JR, Yu DC, et al. Modelling approach for separating blood time-activity curves in positron emission tomographic studies. Phys Med Biol. 1991;36:749-761.
17. 11CJ]WAY-100635 in psychotropic drug development. Nucl Med Biol. 2000;27:515-521.
18. 11C]WAY-100635: explanation of high signal contrast in PET and an aid to biomathematical modelling. Nucl Med Biol. 1998;25:215-223.